Abstract
The effects of fluorinated pyrimidines, 5¢-DFUR, UFT and T-506, on a mouse model of hepatic metastasis were assessed in regard to inhibitory activity and adverse reactions at the maximum tolerated dose. The model was prepared by injecting the mouse colonic cancer cell line, colon 26, into the portal vein of CDF1 mice. At the treatment regimens employed for 5¢-DFUR (1.0mmol/kg/day, p.o., daily from days 1 to 7), UFT (0.1mmol/kg/day, p.o., daily from days 1 to 7), and T-506 (0.074mmol/kg/day, i.v., days 1, 4, 7, and 10), complete inhibition of hepatic metastasis was obtained in six out of seven mice (85.7%) with 5¢-DFUR, and in five out of six mice (83.3%) with T-506. Significant inhibition of hepatic metastasis was not achieved with UFT (3/7, 42.9%). 5¢-DFUR and T-506 showed the highest rate of inhibition of hepatic metastasis, suggesting that these drugs would be effective for the prophylactic treatment of metastatic disease. 5¢-DFUR and UFT exhibited mild adverse reactions such as loss of body weight.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A and Maruyama H, 1980, Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Gann, 71, 112–23.
Choong YS and Lee SP, 1985, The degradation of 5′-deoxy-fluorouridine by pyrimidine nucleoside phosphorylase in normal and cancer tissue. Clinica Chimica Acta, 149, 175–83.
Miwa M, Eda H, Fukuda H, Fujimoto K and Ishitsuka H, 1988, Comparative studies on the antitumor activity of fluorinated pyrimidines, 5′-DFUR, Tagafur, UFT and FUra, with various murine tumors. Jpn J Cancer Chemother, 15, 1755–63.
Miwa M, Cook A and Ishitsuka H, 1986, Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem Pharm Bull, 34, 4225–32.
Yamada Y, Toko T and Miyauchi S, 1980, Effect of UFT on immune responses in mice. Jpn J Cancer Chemother, 7, 2134–40.
Hori T, Miyabara S, Shibata M, Akazawa S and Seno T, 1990, Antitumor activity of T-506, a new synthetic FUDR derivative. J Cancer Res Clin Oncol, 116(Suppl. Part 1), 440.
Uehara N, Baba H, Nitta K, et al. 1985, The therapeutic effect of orally administered 5′-deoxy-5-fluouridine (5′-DFUR), 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) and 5-fluorouracil (5-Fu) on experimental murine tumors. Gann, 76, 1034–41.
Miwa M, Nishimura J, Kamiyama T, iet al. 1987, Conversion of 5`-deoxyfluorouridine to 5-Fu by pyrimidine nucleoside phosphorylase in normal and tumor tissue from rodents bearing tumors and cancer patients. Jpn J Cancer Chemother, 14, 2924–9.
Miyabara S, Shibata M, Tai M, et al. 1989, Studies on a new antitumor agent T-506 (II), antitumor-activity of T-506 against experimental murine tumors. Proceeding of 49th Annual Meeting of the Japanese Cancer Association, p. 376.
Taguchi T, Nakano Y, Jikuya K, et al. 1978, Effect of uracil on the antitumor activity of futraful. Jpn J Cancer Chemother, 5, 1161–5. 1 1
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tazawa , K., Sakamoto , T., Kuroki , Y. et al. Inhibitory effects of fluorinated pyrimidines, 5¢-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma - assessment of inhibitory activity and adverse reactions at the maximum tolerated dose. Clin Exp Metastasis 15, 266–271 (1997). https://doi.org/10.1023/A:1018425532296
Issue Date:
DOI: https://doi.org/10.1023/A:1018425532296